Patent Assignment
Reel/Frame 022988/0752
Assignment of Assignor's Interest
Recorded: 2009-07-22
Pages: 7
Assignee
SCANCELL LIMITED
P.O. BOX 6457, NOTTINGHAM, NG5 1QA, UNITED KINGDOM
Covered Property
(1)
Binding Member Which Binds to Both Lewis-Y and Lewis-B Haptens, and Its Use for Treating Cancer
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 22, 2009
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 022988/0786 →
Change of Name
Sep 1, 2010
From: ARANA THERAPEUTICS LIMITED
To: ARANA THERAPEUTICS PTY LTD
Reel/Frame 024922/0982 →
Change of Name
Sep 2, 2010
From: ARANA THERAPEUTICS PTY LTD
To: CEPHALON AUSTRALIA PTY LTD
Reel/Frame 024929/0966 →
Change of Name
Oct 24, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 031485/0800 →
Corrective Assignment to Correct the Correction of the Assignee Address to Remove "Ron Kal" from the Address Previously Recorded on Reel 031485 Frame 0800. Assignor(S) Hereby Confirms the Name Change from Cephalon Australia Ptyltd to Teva Pharmaceuticals Australia Pty.
Dec 9, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 032269/0198 →